Home
Clinical Trials
Post Vaccination Adverse Even...

Post Vaccination Adverse Events in Covid-19 Vaccine Recipients

Last Updated: 2022-04-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

3515 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-02-26

Study Completion Date

2022-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Covid-19 pandemic is caused by Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-Cov-2) since its outbreak 2019. Protection against Covid-19 can be achieved through global immunization. Various vaccines for SARS-Cov-2 has been registered and approved for administration in humans. It is important to understand the safety and efficacy of vaccines during robust research to develop global immunity against SARS-Cov-2. This study aimed to collect data on post vaccination adverse events in regional population of District Bahawalpur.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Covid-19 Infection in After Vaccination

NCT05033834

Covid19

UNKNOWN

H1N1 Vaccine Safety in Manitoba, Canada

NCT01421251

H1N1 Influenza

UNKNOWN

COVID-19 Vaccines Associated Malaise

NCT05234333

Vaccine Adverse Reaction

COMPLETED

Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom

NCT00996853

Influenza

COMPLETED

Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute

NCT03057483

Influenza Vaccines

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Bahawalpur District of Punjab province has population of 3.998 million and among these 2.6 million above 12 years of age are eligible for vaccination against SARS-Cov-2. 28 centers were established for vaccination within the districts at designated sites for Covid-19 vaccination. 87% targeted population has been vaccinated till 15th February 2022. Investigators designed this study to collect and evaluate data on adverse effects after vaccination of Covid-19. Investigators aimed to collect information through interviewing participants in general places of designated sites of vaccination centers established in District Bahawalpur. History will be recorded from participants and in case of adverse events detailed available history will be recorded including following adverse effects from available records on following.

* Cardiovascular adverse effects
* Cerebrospinal adverse events
* Respiratory disturbances
* Hepatobiliary disorders
* Urogenital adverse effects
* Musculoskeletal adverse effect
* Psychological diseases
* Blood biomarkers changes
* Autoimmune adverse events
* Allergic reactions and hypersensitivity Collected data will be summarized to get percentage of adverse effects in general population. Recorded adverse events will be assessed for their frequency in participants and association with vaccination will be assessed through employing statistical methods. Subsequent information on handling of adverse events will be recorded including
* Nature of adverse event
* Hospitalization and severity of adverse events
* Mortality / morbidity caused by vaccination
* Days of hospitalization
* Changes in Blood biomarkers
* Interventions adopted for adverse events
* Diseased period
* Covid-19 infection positivity through RT-PCR / imaging for round glass opacities / Covid-19 changes Overall efficacy and safety of vaccination will be assessed through collected data.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19 Vaccination Vaccine Adverse Reaction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.